Keros Therapeutics, Inc (KROS)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Jasbir S. Seehra |
| Employees: | 100 |
| Web site: | kerostx.com |
|
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
617-314-6297
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Keros Therapeutics, Inc. focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia.
Please log in first to see chart